*Oita University Faculty of Medicine, 1-1 Hasama-machi, Yufu, Oita 879-5593, Japan.
Jpn J Clin Oncol. 2014 Apr;44(4):305-10. doi: 10.1093/jjco/hyu013. Epub 2014 Mar 3.
Although pre-operative chemoradiation therapy for advanced lower rectal cancer is a controversial treatment modality, it is increasingly used in combination with surgery. Few studies have considered the combination of chemoradiation therapy followed by laparoscopic surgery for locally advanced lower rectal cancer; therefore, this study aimed to assess the usefulness of this therapeutic combination.
We retrospectively reviewed the medical records of patients with locally advanced lower rectal cancer treated by pre-operative chemoradiation therapy and surgery from February 2002 to November 2012 at Oita University. We divided patients into an open surgery group and a laparoscopic surgery group and evaluated various parameters by univariate and multivariate analyses.
In total, 33 patients were enrolled (open surgery group, n = 14; laparoscopic surgery group, n = 19). Univariate analysis revealed that compared with the open surgery group, operative time was significantly longer, whereas intra--operative blood loss and intra-operative blood transfusion requirements were significantly less in the laparoscopic surgery group. There were no significant differences in post-operative complication and recurrence rates between the two groups. According to multivariate analysis, operative time and intra-operative blood loss were significant predictors of outcome in the laparoscopic surgery group.
This study suggests that laparoscopic surgery after chemoradiation therapy for locally advanced lower rectal cancer is a safe procedure. Further prospective investigation of the long-term oncological outcomes of laparoscopic surgery after chemoradiation therapy for locally advanced lower rectal cancer is required to confirm the advantages of laparoscopic surgery over open surgery.
尽管术前放化疗治疗中低位进展期直肠癌存在争议,但该治疗方法越来越多地与手术联合应用。很少有研究考虑过将放化疗联合腹腔镜手术用于局部进展期低位直肠癌;因此,本研究旨在评估这种联合治疗方法的实用性。
我们回顾性分析了 2002 年 2 月至 2012 年 11 月期间在大分大学接受术前放化疗和手术治疗的局部进展期低位直肠癌患者的病历。我们将患者分为开腹手术组和腹腔镜手术组,并通过单因素和多因素分析评估了各种参数。
共纳入 33 例患者(开腹手术组 14 例,腹腔镜手术组 19 例)。单因素分析显示,与开腹手术组相比,腹腔镜手术组的手术时间明显延长,术中出血量和术中输血需求明显减少。两组患者的术后并发症和复发率无显著差异。多因素分析显示,手术时间和术中出血量是腹腔镜手术组预后的显著预测因素。
本研究提示,放化疗后行腹腔镜手术治疗局部进展期低位直肠癌是一种安全的方法。需要进一步前瞻性研究放化疗后行腹腔镜手术治疗局部进展期低位直肠癌的长期肿瘤学结局,以确认腹腔镜手术相对于开腹手术的优势。